US Hemorrhoid Treatment Market Research Report Forecast to 2032

Hemorrhoids treatment refers to medical or surgical interventions aimed at relieving the discomfort and symptoms associated with hemorrhoids, which are swollen or inflamed blood vessels in the rectal or anal area. Treatment can include lifestyle modifications, over-the-counter remedies, minimally invasive procedures, or surgery, depending on the severity of the condition. The goal is to reduce pain, bleeding, itching, and inflammation while improving the patient's quality of life.

The US hemorrhoids treatment market is predicted to expand due to the increasing prevalence of hemorrhoids and growing aging population, and rapid advancements in technology, However, product recall and stringent regulations are limiting market expansion. rising demand in emerging markets on the other hand, boosts the market's attractiveness.

Market Segmentation

Based on the type, the US hemorrhoids treatment market has been segmented into internal hemorrhoids, external hemorrhoids, and prolapsed hemorrhoids.

Based on the treatment type, the market has been segmented into surgical and non-surgical.

Based on the specialist, the US hemorrhoids treatment market has been segmented into proctologist, general physician, and gastroenterologist.

Based on end user, market has been segmented into hospitals & clinics, ambulatory surgical centers, and others.

Major Players

The key players in the US Hemorrhoid Treatment market are Johnson & Johnson Services, Inc, Pfizer Inc., Abbott, Boston Scientific Corporation, Pfizer Inc, CONMED Corporation, Cook Medical, Medtronic Plc, Privi Medical.

1MARKET INTRODUCTION

1.1DEFINITION
1.2SCOPE OF THE STUDY
1.3RESEARCH OBJECTIVE
1.4MARKET STRUCTURE

2RESEARCH METHODOLOGY

2.1OVERVIEW
2.2DATA FLOW
- 2.2.1Data Mining Process
2.3PURCHASED DATABASE:
2.4SECONDARY SOURCES:
- 2.4.1Secondary Research data flow:
2.5PRIMARY RESEARCH:
- 2.5.1Primary Research DATA FLOW:
- 2.5.2Primary Research: Number of Interviews conducted
2.6APPROACHES FOR MARKET SIZE ESTIMATION:
- 2.6.1Revenue Analysis Approach
2.7DATA FORECASTING
- 2.7.1Data forecasting Technique
2.8DATA MODELING
- 2.8.1microeconomic factor analysis:
- 2.8.2Data modeling:
2.9TEAMS AND ANALYST CONTRIBUTION

3MARKET DYNAMICS

3.1INTRODUCTION
3.2DRIVERS
- 3.2.1Increasing Prevalence of Hemorrhoids
- 3.2.2Growing aging population
- 3.2.3NEW APPROACHES TO TREAT HEMORRHOIDS
3.3RESTRAINTS
- 3.3.1Product Recall
3.4OPPORTUNITY
- 3.4.1INNOVATION IN HEMORRHOID TREATMENT DEVICES

4MARKET FACTOR ANALYSIS

4.1VALUE CHAIN ANALYSIS
- 4.1.1R&D and Designing
- 4.1.2Manufacturing
- 4.1.3Distribution
- 4.1.4Post-Sales Monitoring
4.2PORTER'S FIVE FORCES MODEL
- 4.2.1Threat of New Entrants
- 4.2.2Bargaining Power of Suppliers
- 4.2.3Threat of Substitutes
- 4.2.4Bargaining Power of Buyers
- 4.2.5Intensity of Rivalry
4.3IMPACT OF COVID-19 ON THE US HEMORRHOIDS TREATMENT MARKET
- 4.3.1impact on supply chain
- 4.3.2impact on Pricing
- 4.3.3impact on Research and Devlopment

5US HEMORRHOIDS TREATMENT MARKET, BY TYPE

5.1OVERVIEW

6US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE

6.1OVERVIEW

7US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST

7.1OVERVIEW

8US HEMORRHOIDS TREATMENT MARKET, BY END USER

8.1OVERVIEW

9COMPETITIVE LANDSCAPE

9.1INTRODUCTION
9.2MARKET SHARE ANALYSIS, 2022
9.3COMPETITOR DASHBOARD
9.4PUBLIC PLAYERS STOCK SUMMARY
9.5COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

10COMPANY PROFILES

10.1MEDTRONIC PLC
- 10.1.1COMPANY OVERVIEW
- 10.1.2FINANCIAL OVERVIEW
- 10.1.3Products OFFERed
- 10.1.4KEY DEVELOPMENTS
- 10.1.5SWOT ANALYSIS
- 10.1.6Key Strategy
10.2CONMED CORPORATION
- 10.2.1COMPANY OVERVIEW
- 10.2.2FINANCIAL OVERVIEW
- 10.2.3Products OFFERed
- 10.2.4KEY DEVELOPMENTS
- 10.2.5Key Strategy
10.3COOK MEDICAL
- 10.3.1COMPANY OVERVIEW
- 10.3.2FINANCIAL OVERVIEW
- 10.3.3PRODUCTS OFFERED
- 10.3.4Key developments
- 10.3.5SWOT ANALYSIS
- 10.3.6KEY STRATEGIES
10.4PFIZER, INC.
- 10.4.1COMPANY OVERVIEW
- 10.4.2FINANCIAL OVERVIEW
- 10.4.3PRODUCTS OFFERED
- 10.4.4Key developments
- 10.4.5KEY STRATEGIES
10.5JOHNSON & JOHNSON SERVICES, INC.
- 10.5.1COMPANY OVERVIEW
- 10.5.2FINANCIAL OVERVIEW
- 10.5.3Products OFFERed
- 10.5.4KEY DEVELOPMENTS
- 10.5.5SWOT ANALYSIS
- 10.5.6Key Strategy
10.6ABBOTT
- 10.6.1COMPANY OVERVIEW
- 10.6.2FINANCIAL OVERVIEW
- 10.6.3PRODUCTS OFFERED
- 10.6.4KEY DEVELOPMENTS
- 10.6.5SWOT ANALYSIS
- 10.6.6KEY STRATEGIES
10.7BOSTON SCIENTIFIC CORPORATION
- 10.7.1COMPANY OVERVIEW
- 10.7.2FINANCIAL OVERVIEW
- 10.7.3PRODUCTS OFFERED
- 10.7.4KEY DEVELOPMENTS
- 10.7.5SWOT ANALYSIS
- 10.7.6KEY STRATEGIES
10.8INTEGRA LIFESCIENCES
- 10.8.1COMPANY OVERVIEW
- 10.8.2FINANCIAL OVERVIEW
- 10.8.3PRODUCTS OFFERED
- 10.8.4KEY DEVELOPMENTS
- 10.8.5KEY STRATEGIES
10.9SKLAR SURGICAL INSTRUMENTS
- 10.9.1COMPANY OVERVIEW
- 10.9.2FINANCIAL OVERVIEW
- 10.9.3PRODUCTS OFFERED
- 10.9.4KEY DEVELOPMENTS
- 10.9.5KEY STRATEGIES
10.10PRIVI MEDICAL PTE LTD
- 10.10.1COMPANY OVERVIEW
- 10.10.2FINANCIAL OVERVIEW
- 10.10.3PRODUCTS OFFERED
- 10.10.4KEY DEVELOPMENTS
- 10.10.5KEY STRATEGIES

11DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 30
TABLE 2 US HEMORRHOIDS TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION) 46
TABLE 3 US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2032 (USD MILLION) 48
TABLE 4 US HEMORRHOIDS TREATMENT MARKET, FOR SURGICAL, BY TYPE, 2019-2032 (USD MILLION) 48
TABLE 5 US HEMORRHOIDS TREATMENT MARKET, FOR NON-SURGICAL, BY TYPE, 2019-2032 (USD MILLION) 49
TABLE 6 US HEMORRHOIDS TREATMENT MARKET, FOR MEDICATION, BY MEDICATION CHANNEL TYPE, 2019-2032 (USD MILLION) 49
TABLE 7 US HEMORRHOIDS TREATMENT MARKET, FOR MEDICAL DEVICES, BY TYPE, 2019-2032 (USD MILLION) 49
TABLE 8 US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST, 2019-2032 (USD MILLION) 51
TABLE 9 US HEMORRHOIDS TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION) 53
TABLE 10 PUBLIC PLAYERS STOCK SUMMARY 57
TABLE 11 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 57
TABLE 12 MEDTRONIC PLC: PRODCUTS OFFERED 59
TABLE 13 CONMED CORPORATION: PRODUCTS OFFERED 62
TABLE 14 COOK MEDICAL: PRODUCTS OFFERED 64
TABLE 15 PFIZER, INC. : PRODUCTS OFFERED 67
TABLE 16 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 70
TABLE 17 ABBOTT: PRODUCTS OFFERED 73
TABLE 18 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 76
TABLE 19 INTEGRA LIFESCIENCES: PRODUCTS OFFERED 79
TABLE 20 SKLAR SURGICAL INSTRUMENTS: PRODUCTS OFFERED 81
TABLE 21 PRIVI MEDICAL: PRODCUTS OFFERED 83

LIST OF FIGURES

FIGURE 1US HEMORRHOIDS TREATMENT MARKET: STRUCTURE17
FIGURE 2US HEMORRHOIDS TREATMENT MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)34
FIGURE 3DRIVER IMPACT ANALYSIS (2023-2032)36
FIGURE 4RESTRAINT IMPACT ANALYSIS (2022-2032)37
FIGURE 5VALUE CHAIN ANALYSIS OF THE US HEMORRHOIDS TREATMENT MARKET39
FIGURE 6PORTER'S FIVE FORCES ANALYSIS: US HEMORRHOIDS TREATMENT MARKET41
FIGURE 7US HEMORRHOIDS TREATMENT MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)45
FIGURE 8US HEMORRHOIDS TREATMENT MARKET SHARE, BY TYPE, 2022 (%)45
FIGURE 9US HEMORRHOIDS TREATMENT MARKET, BY TYPE, 2022 & 2032 (USD MILLION)46
FIGURE 10US HEMORRHOIDS TREATMENT MARKET, TREATMENT TYPE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)47
FIGURE 11US HEMORRHOIDS TREATMENT MARKET SHARE, BY TREATMENT TYPE, 2022 (%)47
FIGURE 12US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE, 2022 & 2032 (USD MILLION)48
FIGURE 13US HEMORRHOIDS TREATMENT MARKET, SPECIALIST SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)50
FIGURE 14US HEMORRHOIDS TREATMENT MARKET SHARE, BY SPECIALIST, 2022 (%)50
FIGURE 15US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST, 2022 & 2032 (USD MILLION)51
FIGURE 16US HEMORRHOIDS TREATMENT MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)52
FIGURE 17US HEMORRHOIDS TREATMENT MARKET SHARE, BY END USER, 2022 (%)53
FIGURE 18US HEMORRHOIDS TREATMENT MARKET, BY END USER, 2022 & 2032 (USD MILLION)53
FIGURE 19US HEMORRHOIDS TREATMENT MARKET PLAYERS: COMPETITIVE ANALSIS, 202255
FIGURE 20COMPETITOR DASHBOARD: US HEMORRHOIDS TREATMENT MARKET56
FIGURE 21MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT59
FIGURE 22MEDTRONIC PLC: SWOT ANALYSIS60
FIGURE 23CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT62
FIGURE 24COOK MEDICAL: SWOT ANALYSIS65
FIGURE 25PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT67
FIGURE 26JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT70
FIGURE 27JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS71
FIGURE 28ABBOTT: FINANCIAL OVERVIEW SNAPSHOT73
FIGURE 29ABBOTT: SWOT ANALYSIS74
FIGURE 30BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT76
FIGURE 31BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS77
FIGURE 32INTEGRA LIFESCIENCES: FINANCIAL OVERVIEW SNAPSHOT79